208 related articles for article (PubMed ID: 11024283)
1. Rev-binding aptamer and CMV promoter act as decoys to inhibit HIV replication.
Konopka K; Lee NS; Rossi J; Düzgüneş N
Gene; 2000 Sep; 255(2):235-44. PubMed ID: 11024283
[TBL] [Abstract][Full Text] [Related]
2. Receptor ligand-facilitated cationic liposome delivery of anti-HIV-1 Rev-binding aptamer and ribozyme DNAs.
Konopka K; Düzgüneş N; Rossi J; Lee NS
J Drug Target; 1998; 5(4):247-59. PubMed ID: 9713975
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of human immunodeficiency virus-1 production resulting from transduction with a retrovirus containing an HIV-regulated diphtheria toxin A chain gene.
Harrison GS; Long CJ; Curiel TJ; Maxwell F; Maxwell IH
Hum Gene Ther; 1992 Oct; 3(5):461-9. PubMed ID: 1329991
[TBL] [Abstract][Full Text] [Related]
4. Regulation of HIV-1 envelope protein synthesis by Tat and Rev in 293 cells.
Natarajan V; Radjendirane V; Salzman NP
Virology; 1993 Sep; 196(1):122-9. PubMed ID: 8356789
[TBL] [Abstract][Full Text] [Related]
5. Generation of a packaging cell line for prolonged large-scale production of high-titer HIV-1-based lentiviral vector.
Ni Y; Sun S; Oparaocha I; Humeau L; Davis B; Cohen R; Binder G; Chang YN; Slepushkin V; Dropulic B
J Gene Med; 2005 Jun; 7(6):818-34. PubMed ID: 15693055
[TBL] [Abstract][Full Text] [Related]
6. RNA-based anti-HIV-1 gene therapeutic constructs in SCID-hu mouse model.
Bai J; Banda N; Lee NS; Rossi J; Akkina R
Mol Ther; 2002 Dec; 6(6):770-82. PubMed ID: 12498773
[TBL] [Abstract][Full Text] [Related]
7. Diminished production of human immunodeficiency virus type 1 in astrocytes results from inefficient translation of gag, env, and nef mRNAs despite efficient expression of Tat and Rev.
Gorry PR; Howard JL; Churchill MJ; Anderson JL; Cunningham A; Adrian D; McPhee DA; Purcell DF
J Virol; 1999 Jan; 73(1):352-61. PubMed ID: 9847339
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of HIV-1 replication and infectivity by expression of a fusion protein, VPR-anti-integrase single-chain variable fragment (SFv): intravirion molecular therapies.
BouHamdan M; Kulkosky J; Duan LX; Pomerantz RJ
J Hum Virol; 2000; 3(1):6-15. PubMed ID: 10774802
[TBL] [Abstract][Full Text] [Related]
9. Expression of chimeric neo-Rev response element sequences interferes with Rev-dependent HIV-1 Gag expression.
Zimmermann K; Weber S; Dobrovnik M; Hauber J; Böhnlein E
Hum Gene Ther; 1992 Apr; 3(2):155-61. PubMed ID: 1391035
[TBL] [Abstract][Full Text] [Related]
10. Defective HIV-1 provirus encoding a multitarget-ribozyme inhibits accumulation of spliced and unspliced HIV-1 mRNAs, reduces infectivity of viral progeny, and protects the cells from pathogenesis.
Paik SY; Banerjea A; Chen CJ; Ye Z; Harmison GG; Schubert M
Hum Gene Ther; 1997 Jun; 8(9):1115-24. PubMed ID: 9189769
[TBL] [Abstract][Full Text] [Related]
11. Production of human immunodeficiency virus type 1 (HIV-1) pseudoviruses using linear HIV-1 envelope expression cassettes.
Beels D; Heyndrickx L; Vereecken K; Vermoesen T; Michiels L; Vanham G; Kestens L
J Virol Methods; 2008 Jan; 147(1):99-107. PubMed ID: 17904649
[TBL] [Abstract][Full Text] [Related]
12. Regulation of HIV-1 env mRNA translation by Rev protein.
Perales C; Carrasco L; González ME
Biochim Biophys Acta; 2005 Mar; 1743(1-2):169-75. PubMed ID: 15777852
[TBL] [Abstract][Full Text] [Related]
13. Multitarget-ribozyme directed to cleave at up to nine highly conserved HIV-1 env RNA regions inhibits HIV-1 replication--potential effectiveness against most presently sequenced HIV-1 isolates.
Chen CJ; Banerjea AC; Harmison GG; Haglund K; Schubert M
Nucleic Acids Res; 1992 Sep; 20(17):4581-9. PubMed ID: 1408760
[TBL] [Abstract][Full Text] [Related]
14. High level inhibition of HIV replication with combination RNA decoys expressed from an HIV-Tat inducible vector.
Fraisier C; Irvine A; Wrighton C; Craig R; Dzierzak E
Gene Ther; 1998 Dec; 5(12):1665-76. PubMed ID: 10023446
[TBL] [Abstract][Full Text] [Related]
15. Decoy approach using RNA-DNA chimera oligonucleotides to inhibit the regulatory function of human immunodeficiency virus type 1 Rev protein.
Nakaya T; Iwai S; Fujinaga K; Sato Y; Otsuka E; Ikuta K
Antimicrob Agents Chemother; 1997 Feb; 41(2):319-25. PubMed ID: 9021186
[TBL] [Abstract][Full Text] [Related]
16. A multifunctional expression vector for an anti-HIV-1 ribozyme that produces a 5'- and 3'-trimmed trans-acting ribozyme, targeted against HIV-1 RNA, and cis-acting ribozymes that are designed to bind to and thereby sequester trans-activator proteins such as Tat and Rev.
Yuyama N; Ohkawa J; Koguma T; Shirai M; Taira K
Nucleic Acids Res; 1994 Nov; 22(23):5060-7. PubMed ID: 7800500
[TBL] [Abstract][Full Text] [Related]
17. SV40-derived vectors provide effective transgene expression and inhibition of HIV-1 using constitutive, conditional,and pol III promoters.
Jayan GC; Cordelier P; Patel C; BouHamdan M; Johnson RP; Lisziewicz J; Pomerantz RJ; Strayer DS
Gene Ther; 2001 Jul; 8(13):1033-42. PubMed ID: 11438838
[TBL] [Abstract][Full Text] [Related]
18. A DEAD box protein facilitates HIV-1 replication as a cellular co-factor of Rev.
Fang J; Kubota S; Yang B; Zhou N; Zhang H; Godbout R; Pomerantz RJ
Virology; 2004 Dec; 330(2):471-80. PubMed ID: 15567440
[TBL] [Abstract][Full Text] [Related]
19. Expression of human immunodeficiency virus 1 (HIV-1) envelope gene products transcribed from a heterologous promoter. Kinetics of HIV-1 envelope processing in transfected cells.
Bird C; Burke J; Gleeson PA; McCluskey J
J Biol Chem; 1990 Nov; 265(31):19151-7. PubMed ID: 2229068
[TBL] [Abstract][Full Text] [Related]
20. A chimeric human immunodeficiency virus type 1 (HIV-1) minimal Rev response element-ribozyme molecule exhibits dual antiviral function and inhibits cell-cell transmission of HIV-1.
Yamada O; Kraus G; Luznik L; Yu M; Wong-Staal F
J Virol; 1996 Mar; 70(3):1596-601. PubMed ID: 8627679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
